Impact of Antimicrobial Stewardship Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04039152|
Recruitment Status : Recruiting
First Posted : July 31, 2019
Last Update Posted : August 15, 2019
|Condition or disease||Intervention/treatment|
|Blood Stream Infections||Other: Clinical pharmacists recommendations to optimize antibiotics use|
- The Ultimate aims of antimicrobial stewardship program are to improve antimicrobials efficacy, minimize their adverse effects and limit antimicrobial resistance.
- The aim of this study is to measure the clinical & economic impact of antimicrobial stewardship program interventions.
• Prospective-audit with feedback program strategy (Single-center, prospective, pre- and post-intervention study).
• This study will be conducted in Neonatal Intensive Care Unit of Assiut University Children's Hospital, Assiut University, Assiut, Egypt.
• 12- 18 months.
• This study approved by the University Ethics Medical Committee. Informed consent is unnecessary since antimicrobial stewardship program interventions represent a part of routine clinical practice. Patients records will be identified by coded numbers to maintain privacy.
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Impact of Antimicrobial Stewardship Program on Antibiotics Use in Neonatal Intensive Care Unit at Assiut University Children's Hospital|
|Actual Study Start Date :||November 1, 2018|
|Estimated Primary Completion Date :||June 2020|
|Estimated Study Completion Date :||July 2020|
Pre- interventions group
Without clinical pharmacists recommendations to optimize antibiotics use
Post - interventions group
interventions include clinical pharmacists recommendations to optimize antibiotics use
Other: Clinical pharmacists recommendations to optimize antibiotics use
Optimal dosing, drug bug mismatch
- Mortality rate in each group [ Time Frame: 18 month ]Number of deaths
- Average Length of hospital stay in each group [ Time Frame: 18 month ]In days
- Total Antibiotics consumption [ Time Frame: 18 month ]in the form of defined daily doses
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04039152
|Contact: Neveen Abdelaalfirstname.lastname@example.org|
|Assiut, Egypt, 71511|
|Contact: Neveen Abdelaal 00201005647073 email@example.com|